Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News Spectral AI Inc MDAI

Healthcare Medical Devices
Spectral AI, Inc. is a predictive artificial intelligence (AI) company focused on medical diagnostics for faster and more accurate treatment decisions in wound care, with initial applications involving patients with burns. The Company's DeepView platform is a predictive device that offers clinicians an objective and immediate assessment of a wound healing potential prior to treatment or other... see more

Recent & Breaking News (NDAQ:MDAI)

Spectral AI Announces 2024 First Quarter Financial Results

GlobeNewswire May 7, 2024

Spectral AI to Participate at the Sidoti Micro-Cap Virtual Investor Conference

GlobeNewswire May 2, 2024

Spectral AI Awarded Quality Achievement Award from the Texas Manufacturer Assistance Center

GlobeNewswire April 30, 2024

Spectral AI Schedules 2024 First Quarter Financial Results and Conference Call

GlobeNewswire April 24, 2024

Spectral AI Names Erich Spangenberg CEO of its IP Focused Subsidiary and Explores Potential Spin-Off of that Subsidiary

GlobeNewswire April 24, 2024

Spectral AI Appoints Jeremiah Sparks as Chief Commercialization Officer

GlobeNewswire April 1, 2024

Spectral AI Announces 2023 Fourth Quarter and Full Year Financial Results

GlobeNewswire March 27, 2024

Spectral AI Secures Access to $12.5 Million of New Equity Capital

GlobeNewswire March 20, 2024

Spectral AI Announces Receipt of $1 Million of Financing for Spectral IP, Inc., its Intellectual Property Subsidiary Focused on the Broader Artificial Intelligence Ecosystem

GlobeNewswire March 19, 2024

Spectral AI Schedules 2023 Fourth Quarter and Full Year Financial Results and Conference Call

GlobeNewswire March 13, 2024

Spectral AI Announces New US Government Contract to Further Accelerate the Development of the Handheld Version of DeepView(TM) Wound Imaging System

GlobeNewswire March 12, 2024

Spectral AI Announces Intellectual Property Subsidiary to Focus on the Broader AI Healthcare Ecosystem

GlobeNewswire March 7, 2024

Spectral AI Appoints Peter M. Carlson as CEO

GlobeNewswire February 29, 2024

Spectral AI to Participate in Upcoming Investor Conferences

GlobeNewswire February 28, 2024

Spectral Receives UKCA Authorization for Burn Indication Expected Commercialization 2nd Half 2024

GlobeNewswire February 22, 2024

Spectral AI Appoints Dr. J. Michael DiMaio to Board of Directors

GlobeNewswire February 12, 2024

Spectral AI to Participate in the 2024 BTIG MedTech, Digital Health, Life Science & Diagnostic Tools Conference

GlobeNewswire February 6, 2024

Spectral AI Announces Publication of Letter to Shareholders

GlobeNewswire February 5, 2024

Spectral Submits Application for UKCA Mark Classification

GlobeNewswire January 29, 2024

Thinking about buying stock in Spectral AI, Applied UV, Adobe, BigBear.ai, or Aclarion?

PR Newswire January 29, 2024